All Stories

  1. Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysis

    Article • Lung Cancer Targets and Therapy, January 2019, Dove Medical Press

    Professor ANURADHA CHOUGHULE, Dr kumar prabhash

  2. Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer

    Article • Lung Cancer Targets and Therapy, January 2018, Dove Medical Press

    Professor ANURADHA CHOUGHULE, Dr kumar prabhash, Vidya Veldore

  3. Phase III randomized trial comparing intravenous to oral iron in patients with cancer-related iron deficiency anemia not on erythropoiesis stimulating agents

    Article • Asia-Pacific Journal of Clinical Oncology, August 2017, Wiley

    Dr kumar prabhash

  4. Epidermal growth factor receptor exon 20 mutation in lung cancer: types, incidence, clinical features and impact on treatment

    Article • OncoTargets and Therapy, June 2017, Dove Medical Press

    Professor ANURADHA CHOUGHULE, Dr kumar prabhash

  5. EGFR mutation in squamous cell carcinoma Lung

    Article • OncoTargets and Therapy, March 2017, Dove Medical Press

    Dr kumar prabhash, Dr Akhil Kapoor, Dr Saurabh Zanwar , Professor ANURADHA CHOUGHULE, AMIT JANU

  6. Efficacy of Second-Line Pemetrexed-Carboplatin in EGFR-Activating Mutation-Positive NSCLC: Does Exon 19 Deletion Differ from Exon 21 Mutation?

    Article • Chemotherapy Research and Practice, January 2017, Hindawi Publishing Corporation

    Dr kumar prabhash, Alok Goel, Professor ANURADHA CHOUGHULE, AMIT JANU, Ashay Karpe, Atanu Bhattacharjee

  7. Response to docetaxel and cisplatin induction chemotherapy of locally advanced head and neck squamous cell carcinoma: a multicenter, non-comparative, open-label interventional pilot study

    Article • The Journal of Laryngology & Otology, July 2016, Cambridge University Press

    Dr kumar prabhash

  8. Clinical Outcome in Definitive Concurrent Chemoradiation With Weekly Paclitaxel and Carboplatin for Locally Advanced Esophageal and Junctional Cancer

    Article • Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, March 2016, Cognizant Communication Corporation

    Dr kumar prabhash

  9. CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons

    Article • F1000Research, June 2015, Faculty of 1000, Ltd.

    Dr kumar prabhash, Dr. Kuldeep Patel, Professor ANURADHA CHOUGHULE

  10. Clinical and epidemiological study of EGFR mutations and EML4-ALK fusion genes among Indian patients with adenocarcinoma of the lung

    Article • OncoTargets and Therapy, January 2015, Taylor & Francis

    Mr Sanjay Gupta, Dr DINESH CHANDRA DOVAL, Dr kumar prabhash

  11. Excellent response to oral Metronomic chemotherapy in unresectable adenocarcinoma of external auditory canal

    Article • Indian Journal of Medical and Paediatric Oncology, January 2015, Medknow

    Dr kumar prabhash

  12. Metronomic chemotherapy in platinum-insensitive failures and/or early failures postmultimodality management in oral cancers

    Article • Indian Journal of Medical and Paediatric Oncology, January 2015, Medknow

    Dr kumar prabhash

  13. Neoadjuvant chemotherapy in technically unresectable carcinoma of external auditory canal

    Article • Indian Journal of Medical and Paediatric Oncology, January 2015, Medknow

    Dr kumar prabhash

  14. Maintenance pemetrexed in nonsmall cell lung carcinoma: Outcome analysis from a tertiary care center

    Article • Indian Journal of Medical and Paediatric Oncology, January 2015, Medknow

    Dr kumar prabhash

  15. Comparison of postoperative complications in advanced head and neck cancer patients receiving neoadjuvant chemotherapy followed by surgery versus surgery alone

    Article • Indian Journal of Medical and Paediatric Oncology, January 2015, Medknow

    Dr kumar prabhash

  16. Renal impairment in prostate cancer: A close look is important

    Article • Indian Journal of Cancer, January 2015, Medknow

    Dr kumar prabhash

  17. Is taxane/platinum/5 fluorouracil superior to taxane/platinum alone and does docetaxel trump paclitaxel in induction therapy for locally advanced oral cavity cancers?

    Article • Indian Journal of Cancer, January 2015, Medknow

    Dr kumar prabhash

  18. Neoadjuvant chemotherapy in advanced sinonasal teratocarcinosarcoma with intracranial extension: Report of two cases with literature review

    Article • Journal of Cancer Research and Therapeutics, January 2015, Medknow

    Dr kumar prabhash

  19. Chemotherapy for obstructive atelectasis in nonsmall cell lung cancer: Is this a treatment option?

    Article • Indian Journal of Cancer, January 2015, Medknow

    Dr kumar prabhash

  20. High plasma exposure to pemetrexed leads to severe hyponatremia in patients with advanced non small cell lung cancer receiving pemetrexed-platinum doublet chemotherapy

    Article • Cancer Management and Research, June 2014, Taylor & Francis

    Dr Kartik Himmat Doshi, Dr kumar prabhash, Murari (Chemistry)

  21. Weekly chemotherapy as Induction chemotherapy in locally advanced head and neck cancer for patients ineligible for 3 weekly maximum tolerable dose chemotherapy

    Article • Indian Journal of Cancer, January 2014, Medknow

    Dr kumar prabhash

  22. Beyond ten cycles of cabazitaxel for castrate-resistant prostate cancer

    Article • Indian Journal of Cancer, January 2014, Medknow

    Dr kumar prabhash

  23. Recurrent sinonasal teratocarcinosarcoma with intracranial extension: Case report

    Article • Indian Journal of Cancer, January 2014, Medknow

    Dr kumar prabhash

  24. Response to oral metronomic chemotherapy in carcinoma of the Buccal Mucosa: A case report

    Article • Indian Journal of Cancer, January 2014, Medknow

    Dr kumar prabhash

  25. Oral cutaneous leishmaniasis mimicking carcinoma of tongue: A case report

    Article • Indian Journal of Cancer, January 2014, Medknow

    Dr kumar prabhash

  26. Pattern of infection, therapy, outcome and risk stratification of patients with febrile neutropenia in a tertiary care oncology hospital in India

    Article • Indian Journal of Cancer, January 2014, Medknow

    Dr kumar prabhash

  27. The utility of molecular testing in the futility of definite therapy

    Article • Indian Journal of Cancer, January 2014, Medknow

    Dr kumar prabhash